NEUCA Past Earnings Performance
Past criteria checks 5/6
NEUCA has been growing earnings at an average annual rate of 3%, while the Healthcare industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 8.7% per year. NEUCA's return on equity is 13.1%, and it has net margins of 1.3%.
Key information
3.0%
Earnings growth rate
2.4%
EPS growth rate
| Healthcare Industry Growth | 13.7% |
| Revenue growth rate | 8.7% |
| Return on equity | 13.1% |
| Net Margin | 1.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
What NEUCA S.A.'s (WSE:NEU) P/E Is Not Telling You
Dec 12
NEUCA's (WSE:NEU) Performance Is Even Better Than Its Earnings Suggest
Nov 25NEUCA (WSE:NEU) Might Become A Compounding Machine
Nov 20NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price
Sep 19Returns On Capital At NEUCA (WSE:NEU) Have Stalled
Aug 13Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)
Jul 19NEUCA (WSE:NEU) Seems To Use Debt Quite Sensibly
Mar 08Returns On Capital At NEUCA (WSE:NEU) Have Stalled
Dec 29Here's Why NEUCA (WSE:NEU) Can Manage Its Debt Responsibly
Dec 05NEUCA (WSE:NEU) Hasn't Managed To Accelerate Its Returns
Apr 16An Intrinsic Calculation For NEUCA S.A. (WSE:NEU) Suggests It's 32% Undervalued
Jan 17Capital Investment Trends At NEUCA (WSE:NEU) Look Strong
Oct 25Here's Why We Think NEUCA (WSE:NEU) Is Well Worth Watching
Aug 04Is There An Opportunity With NEUCA S.A.'s (WSE:NEU) 34% Undervaluation?
Jul 01Returns On Capital At NEUCA (WSE:NEU) Have Stalled
Jun 18NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50
Apr 21NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50
Apr 07NEUCA (WSE:NEU) Knows How To Allocate Capital
Mar 15Does NEUCA (WSE:NEU) Have A Healthy Balance Sheet?
Jan 03Is NEUCA (WSE:NEU) Using Too Much Debt?
Jun 14With EPS Growth And More, NEUCA (WSE:NEU) Is Interesting
May 19Investors Shouldn't Overlook NEUCA's (WSE:NEU) Impressive Returns On Capital
Mar 30A Look At The Fair Value Of NEUCA S.A. (WSE:NEU)
Mar 15Did You Participate In Any Of NEUCA's (WSE:NEU) Fantastic 211% Return ?
Mar 02Is Now The Time To Put NEUCA (WSE:NEU) On Your Watchlist?
Feb 18Is NEUCA S.A.'s(WSE:NEU) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 06Should You Rely On NEUCA's (WSE:NEU) Earnings Growth?
Jan 26
The Case For NEUCA S.A. (WSE:NEU): Could It Be A Nice Addition To Your Dividend Portfolio?
Jan 15Is NEUCA (WSE:NEU) Using Too Much Debt?
Jan 04The Trend Of High Returns At NEUCA (WSE:NEU) Has Us Very Interested
Dec 23Is NEUCA S.A. (WSE:NEU) Trading At A 24% Discount?
Dec 13Could The NEUCA S.A. (WSE:NEU) Ownership Structure Tell Us Something Useful?
Dec 03Announcing: NEUCA (WSE:NEU) Stock Increased An Energizing 122% In The Last Three Years
Nov 23Revenue & Expenses Breakdown
How NEUCA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 12,343 | 161 | 1,149 | 0 |
| 30 Jun 24 | 12,125 | 165 | 1,117 | 0 |
| 31 Mar 24 | 11,973 | 155 | 1,072 | 0 |
| 31 Dec 23 | 11,813 | 146 | 1,056 | 0 |
| 30 Sep 23 | 11,813 | 128 | 1,018 | 0 |
| 30 Jun 23 | 11,654 | 108 | 991 | 0 |
| 31 Mar 23 | 11,418 | 125 | 932 | 0 |
| 31 Dec 22 | 11,232 | 137 | 892 | 0 |
| 30 Sep 22 | 10,962 | 148 | 877 | 0 |
| 30 Jun 22 | 10,705 | 163 | 831 | 0 |
| 31 Mar 22 | 10,381 | 161 | 813 | 0 |
| 31 Dec 21 | 9,864 | 151 | 777 | 0 |
| 30 Sep 21 | 9,575 | 144 | 731 | 0 |
| 30 Jun 21 | 9,329 | 149 | 714 | 0 |
| 31 Mar 21 | 8,907 | 142 | 681 | 0 |
| 31 Dec 20 | 9,245 | 142 | 683 | 0 |
| 30 Sep 20 | 8,996 | 148 | 674 | 0 |
| 30 Jun 20 | 8,695 | 131 | 657 | 0 |
| 31 Mar 20 | 8,772 | 130 | 681 | 0 |
| 31 Dec 19 | 8,272 | 117 | 650 | 0 |
| 30 Sep 19 | 8,079 | 116 | 630 | 0 |
| 30 Jun 19 | 7,941 | 113 | 633 | 0 |
| 31 Mar 19 | 7,731 | 100 | 628 | 0 |
| 31 Dec 18 | 7,753 | 95 | 636 | 0 |
| 30 Sep 18 | 7,700 | 103 | 632 | 0 |
| 30 Jun 18 | 7,643 | 99 | 625 | 0 |
| 31 Mar 18 | 7,645 | 95 | 611 | 0 |
| 31 Dec 17 | 7,485 | 94 | 598 | 0 |
| 30 Sep 17 | 7,433 | 91 | 590 | 0 |
| 30 Jun 17 | 7,321 | 97 | 582 | 0 |
| 31 Mar 17 | 7,217 | 107 | 570 | 0 |
| 31 Dec 16 | 7,077 | 112 | 552 | 0 |
| 30 Sep 16 | 6,946 | 108 | 551 | 0 |
| 30 Jun 16 | 6,897 | 105 | 540 | 0 |
| 31 Mar 16 | 6,920 | 105 | 538 | 0 |
| 31 Dec 15 | 6,946 | 101 | 539 | 0 |
| 30 Sep 15 | 7,011 | 113 | 536 | 0 |
| 30 Jun 15 | 7,100 | 100 | 536 | 0 |
| 31 Mar 15 | 6,957 | 89 | 525 | 0 |
| 31 Dec 14 | 6,569 | 93 | 498 | 0 |
| 30 Sep 14 | 6,199 | 72 | 472 | 0 |
| 30 Jun 14 | 5,897 | 80 | 445 | 0 |
| 31 Mar 14 | 5,759 | 89 | 428 | 0 |
| 31 Dec 13 | 5,795 | 85 | 431 | 0 |
Quality Earnings: NEU has high quality earnings.
Growing Profit Margin: NEU's current net profit margins (1.3%) are higher than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEU's earnings have grown by 3% per year over the past 5 years.
Accelerating Growth: NEU's earnings growth over the past year (26.3%) exceeds its 5-year average (3% per year).
Earnings vs Industry: NEU earnings growth over the past year (26.3%) exceeded the Healthcare industry 26.3%.
Return on Equity
High ROE: NEU's Return on Equity (13.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 07:50 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NEUCA S.A. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sylwia Jaskiewicz | Dom Maklerski IDMSA |
| Cezary Bernatek | Erste Group Bank AG |
| Lukasz Kosiarski | Ipopema Securities S.A. |